351 related articles for article (PubMed ID: 29542187)
1. Multiplex PCR in noninvasive prenatal diagnosis for FGFR3-related disorders.
Terasawa S; Kato A; Nishizawa H; Kato T; Yoshizawa H; Noda Y; Miyazaki J; Ito M; Sekiya T; Fujii T; Kurahashi H
Congenit Anom (Kyoto); 2019 Jan; 59(1):4-10. PubMed ID: 29542187
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth receptor-3 (FGFR3) G375C mutation in a case of achondroplasia and thanatophoric dysplasia phenotypic overlap.
Barton C; Sweeney E; Roberts D; McPartland J
Clin Dysmorphol; 2010 Jul; 19(3):146-149. PubMed ID: 20357663
[No Abstract] [Full Text] [Related]
3. Occurrence of thanatophoric dysplasia type I (R248C) and hypochondroplasia (N540K) mutations in two patients with achondroplasia phenotype.
Camera G; Baldi M; Strisciuglio G; Concolino D; Mastroiacovo P; Baffico M
Am J Med Genet; 2001 Dec; 104(4):277-81. PubMed ID: 11754059
[TBL] [Abstract][Full Text] [Related]
4. Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism.
Bonaventure J; Rousseau F; Legeai-Mallet L; Le Merrer M; Munnich A; Maroteaux P
Am J Med Genet; 1996 May; 63(1):148-54. PubMed ID: 8723101
[TBL] [Abstract][Full Text] [Related]
5. A case of thanatophoric dysplasia: the early prenatal 2D and 3D sonographic findings and molecular confirmation of diagnosis.
Wong HS; Kidd A; Zuccollo J; Tuohy J; Strand L; Tait J; Pringle KC
Fetal Diagn Ther; 2008; 24(1):71-3. PubMed ID: 18504386
[TBL] [Abstract][Full Text] [Related]
6. Rapid detection of K650E mutation in FGFR3 using uncultured amniocytes in a pregnancy affected with fetal cloverleaf skull, occipital pseudoencephalocele, ventriculomegaly, straight short femurs, and thanatophoric dysplasia type II.
Chen CP; Chang TY; Lin MH; Chern SR; Su JW; Wang W
Taiwan J Obstet Gynecol; 2013 Sep; 52(3):420-5. PubMed ID: 24075385
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive prenatal test for FGFR3-related skeletal dysplasia based on next-generation sequencing and plasma cell-free DNA: Test performance analysis and feasibility exploration.
Ren Y; Zhao J; Li R; Xie Y; Jiang S; Zhou H; Liu H; You Y; Chen F; Wang W; Gao Y; Meng Y; Lu Y
Prenat Diagn; 2018 Oct; 38(11):821-828. PubMed ID: 30048571
[TBL] [Abstract][Full Text] [Related]
8. Perinatal imaging findings and molecular genetic analysis of thanatophoric dysplasia type 1 in a fetus with a c.2419T>G (p.Ter807Gly) (X807G) mutation in FGFR3.
Chen SW; Chen CP; Wang LK; Chern SR; Wu PC; Chen YN; Lin CJ; Chen WL; Wang W
Taiwan J Obstet Gynecol; 2017 Feb; 56(1):87-92. PubMed ID: 28254233
[TBL] [Abstract][Full Text] [Related]
9. Rapid detection of common mutations of the FGFR3 gene causing thanatophoric dysplasia type I: two case reports.
Yang Y; Liu YN; Li DZ
Fetal Pediatr Pathol; 2012 Jun; 31(3):128-33. PubMed ID: 22414243
[TBL] [Abstract][Full Text] [Related]
10. Sonographic and molecular diagnosis of thanatophoric dysplasia type I at 18 weeks of gestation.
De Biasio P; Prefumo F; Baffico M; Baldi M; Priolo M; Lerone M; Tomà P; Venturini PL
Prenat Diagn; 2000 Oct; 20(10):835-7. PubMed ID: 11038465
[TBL] [Abstract][Full Text] [Related]
11. Bone dysplasia series. Achondroplasia, hypochondroplasia and thanatophoric dysplasia: review and update.
Lemyre E; Azouz EM; Teebi AS; Glanc P; Chen MF
Can Assoc Radiol J; 1999 Jun; 50(3):185-97. PubMed ID: 10405653
[TBL] [Abstract][Full Text] [Related]
12. Thanatophoric dysplasia: a case report.
Jagun OE; Olusola-Bello MA; Adekanmbi AF; Jagun OO; Oduwole T
Pan Afr Med J; 2020; 37():220. PubMed ID: 33520059
[TBL] [Abstract][Full Text] [Related]
13. Safe, accurate, prenatal diagnosis of thanatophoric dysplasia using ultrasound and free fetal DNA.
Chitty LS; Khalil A; Barrett AN; Pajkrt E; Griffin DR; Cole TJ
Prenat Diagn; 2013 May; 33(5):416-23. PubMed ID: 23408600
[TBL] [Abstract][Full Text] [Related]
14. Atypical achondroplasia due to somatic mosaicism for the common thanatophoric dysplasia mutation R248C.
Takagi M; Kaneko-Schmitt S; Suzumori N; Nishimura G; Hasegawa T
Am J Med Genet A; 2012 Jan; 158A(1):247-50. PubMed ID: 22106050
[No Abstract] [Full Text] [Related]
15. Thanatophoric dysplasia type I associated with increased nuchal translucency in the first trimester: Early prenatal diagnosis using combined ultrasonography and molecular biology.
Tonni G; Azzoni D; Ventura A; Ferrari B; Felice CD; Baldi M
Fetal Pediatr Pathol; 2010; 29(5):314-22. PubMed ID: 20704477
[TBL] [Abstract][Full Text] [Related]
16. Prenatal ultrasound and MRI findings of temporal and occipital lobe dysplasia in a twin with achondroplasia.
Pugash D; Lehman AM; Langlois S
Ultrasound Obstet Gynecol; 2014 Sep; 44(3):365-8. PubMed ID: 24616001
[TBL] [Abstract][Full Text] [Related]
17. Identification and in silico characterization of p.G380R substitution in FGFR3, associated with achondroplasia in a non-consanguineous Pakistani family.
Ajmal M; Mir A; Shoaib M; Malik SA; Nasir M
Diagn Pathol; 2017 Jul; 12(1):47. PubMed ID: 28679403
[TBL] [Abstract][Full Text] [Related]
18. Increased first-trimester nuchal translucency associated with thanatophoric dysplasia type 1.
Zhen L; Pan M; Han J; Yang X; Liao C; Li DZ
J Obstet Gynaecol; 2015; 35(7):685-7. PubMed ID: 25671245
[TBL] [Abstract][Full Text] [Related]
19. Second trimester molecular diagnosis of a stop codon FGFR3 mutation in a type I thanatophoric dysplasia fetus following abnormal ultrasound findings.
Chen CP; Chern SR; Chang TY; Lin CJ; Wang W; Tzen CY
Prenat Diagn; 2002 Aug; 22(8):736-7. PubMed ID: 12210587
[No Abstract] [Full Text] [Related]
20. Identification of a novel insertion mutation in FGFR3 that causes thanatophoric dysplasia type 1.
Lindy AS; Basehore MJ; Munisha M; Williams AL; Friez MJ; Writzl K; Willems P; Dougan ST
Am J Med Genet A; 2016 Jun; 170(6):1573-9. PubMed ID: 27028100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
